Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117786292 | 11778629 | 2 | F | 20160920 | 20151125 | 20160929 | EXP | US-PFIZER INC-2015390259 | PFIZER | 62.00 | YR | M | Y | 0.00000 | 20160929 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117786292 | 11778629 | 1 | PS | DOCETAXEL. | DOCETAXEL | 1 | UNK | U | 202356 | ||||||||||
| 117786292 | 11778629 | 2 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 160 MG, 1X/DAY | 0 | 160 | MG | CAPSULE | QD | ||||||
| 117786292 | 11778629 | 3 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 160 MG, 1X/DAY | 0 | 160 | MG | CAPSULE | QD | ||||||
| 117786292 | 11778629 | 4 | C | PENTASA | MESALAMINE | 1 | UNK | 0 | |||||||||||
| 117786292 | 11778629 | 5 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 117786292 | 11778629 | 6 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | 0 | ||||||||||||
| 117786292 | 11778629 | 7 | C | BICALUTAMIDE. | BICALUTAMIDE | 1 | UNK | 0 | |||||||||||
| 117786292 | 11778629 | 8 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK | 0 | |||||||||||
| 117786292 | 11778629 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 117786292 | 11778629 | 10 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 117786292 | 11778629 | 11 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 117786292 | 11778629 | 12 | C | ENTOCORT | BUDESONIDE | 1 | UNK | 0 | |||||||||||
| 117786292 | 11778629 | 13 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 117786292 | 11778629 | 14 | C | NEURONTIN | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 117786292 | 11778629 | 15 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117786292 | 11778629 | 1 | Product used for unknown indication |
| 117786292 | 11778629 | 2 | Prostate cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117786292 | 11778629 | HO |
| 117786292 | 11778629 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117786292 | 11778629 | Bladder neoplasm | |
| 117786292 | 11778629 | Crohn's disease | |
| 117786292 | 11778629 | Disease recurrence | |
| 117786292 | 11778629 | Drug dose omission | |
| 117786292 | 11778629 | Malaise | |
| 117786292 | 11778629 | Malignant melanoma | |
| 117786292 | 11778629 | Neuropathy peripheral | |
| 117786292 | 11778629 | Second primary malignancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117786292 | 11778629 | 2 | 20150108 | 201502 | 0 | |
| 117786292 | 11778629 | 3 | 20150223 | 0 |